{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:41:11Z","timestamp":1793601671997,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1053\/j.semnuclmed.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T16:00:57Z","timestamp":1680278457000},"page":"706-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Histopathologically Validated Diagnostic Accuracy of PSMA-PET\/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET\/CT on Clinical Management: A Systematic Review and Meta-analysis"],"prefix":"10.1053","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3765-5310","authenticated-orcid":false,"given":"Varinder","family":"Jeet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2137-0962","authenticated-orcid":false,"given":"Bonny","family":"Parkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1396-2551","authenticated-orcid":false,"given":"Rachel","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4474-5296","authenticated-orcid":false,"given":"Rajan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hoyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0001","first-page":"209","article-title":"global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0002","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1002\/cncr.31026","article-title":"Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study, United States","volume":"123","author":"Steele","year":"2017","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0003","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG Guidelines on prostate cancer. part 1: Screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0004","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/bju.13104","article-title":"Guideline of guidelines: Imaging of localized prostate cancer","volume":"116","author":"Wollin","year":"2015","journal-title":"BJU Int"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/028418602320405005","article-title":"Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice","volume":"41","author":"Salminen","year":"2002","journal-title":"Acta Oncol"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0006","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0007","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00268-005-0544-5","article-title":"Expression of prostate-specific membrane antigen in normal and malignant human tissues","volume":"30","author":"Kinoshita","year":"2006","journal-title":"World J Surg"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0008","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.humpath.2006.11.012","article-title":"Prostate-specific membrane antigen expression as a predictor of prostate cancer progression","volume":"38","author":"Perner","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0009","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.juro.2015.12.025","article-title":"Diagnostic Efficacy of (68)Gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer","volume":"195","author":"Maurer","year":"2016","journal-title":"J Urol"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 update. Part 1: Screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0011","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/bju.14374","article-title":"A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET\/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol","volume":"122","author":"Hofman","year":"2018","journal-title":"BJU Int"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0012","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2019","journal-title":"Eur Urol"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0013","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.euf.2016.11.002","article-title":"(68)ga-labeled prostate-specific membrane antigen ligand positron emission tomography\/computed tomography for prostate cancer: A systematic review and meta-analysis","volume":"4","author":"von Eyben","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0014","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0015","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0016","unstructured":"Covidence systematic review software, Melbourne, Australia, Veritas Health Innovation, Available at: www.covidence.org."},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0017","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0018","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group","volume":"4","author":"Atkins","year":"2004","journal-title":"Bmc Health Serv Res"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0019","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0020","series-title":"Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0","article-title":"Chapter 4: Guide to the contents of a Cochrane Diagnostic Test Accuracy Protocol","author":"Deeks","year":"2013"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0021","series-title":"Cochrane handbook for systematic reviews of diagnostic test accuracy","first-page":"83","author":"Macaskill","year":"2010"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0022","unstructured":"Dwamena B. MIDAS: Stata module for meta-analytical integration of diagnostic test accuracy studies. Boston, United States, 2009."},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0023","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/hrt.2010.212084","article-title":"Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis","volume":"97","author":"Janda","year":"2011","journal-title":"Heart"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0024","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/sim.942","article-title":"A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations","volume":"20","author":"Rutter","year":"2001","journal-title":"Stat Med"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0025","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the accuracy of diagnostic systems","volume":"240","author":"Swets","year":"1988","journal-title":"Science"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0026","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-120-8-199404150-00008","article-title":"Guidelines for meta-analyses evaluating diagnostic tests","volume":"120","author":"Irwig","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0027","first-page":"675","article-title":"Meta-analyses of studies of the diagnostic accuracy of laboratory tests: a review of the concepts and methods","volume":"122","author":"Vamvakas","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0028","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0029","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.282.11.1061","article-title":"Empirical evidence of design-related bias in studies of diagnostic tests","volume":"282","author":"Lijmer","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0030","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed","volume":"58","author":"Deeks","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0031","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0032","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.euf.2016.11.002","article-title":"Ga-68-labeled prostate-specific membrane antigen ligand positron emission tomography\/computed tomography for prostate cancer: A systematic review and meta-analysis","volume":"4","author":"von Eyben","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0033","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2967\/jnumed.118.219501","article-title":"Metaanalysis of (68)Ga-PSMA-11 PET Accuracy for the detection of prostate cancer validated by histopathology","volume":"60","author":"Hope","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0034","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000493169","volume":"102","author":"Kim","year":"2019","journal-title":"Urol Int"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"Hovels","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0036","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.eururo.2012.09.039","article-title":"Utility of choline positron emission tomography\/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis","volume":"63","author":"Evangelista","year":"2013","journal-title":"Eur Urol"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0037","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1038\/s41598-018-22594-1","article-title":"PSMA expression: A potential ally for the pathologist in prostate cancer diagnosis","volume":"8","author":"Bravaccini","year":"2018","journal-title":"Sci Rep"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0038","unstructured":"Howlader N, Noone A, Krapcho M, et al. Cronin KA (eds) SEER Cancer Statistics Review (CSR) 1975-2016. Bethesda, MD, National Cancer Institute, [Google Scholar]. 1975."},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0039","first-page":"S3","article-title":"Risk factors for prostate cancer","volume":"4","author":"Gann","year":"2002","journal-title":"Rev Urol"},{"key":"10.1053\/j.semnuclmed.2023.02.006_bib0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.eururo.2018.03.030","article-title":"Impact of (68)Ga-PSMA PET on the management of patients with prostate cancer: A systematic review and meta-analysis","volume":"74","author":"Han","year":"2018","journal-title":"Eur Urol"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299823000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299823000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:00:25Z","timestamp":1762074025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299823000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0001299823000120"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.02.006","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathologically Validated Diagnostic Accuracy of PSMA-PET\/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET\/CT on Clinical Management: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}